Health in Canada

Results: 16457



#Item
12013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

2013 Annual Report HARNESSING A NEW ERA OF PARTNERSHIPS AND NETWORKS IN HEALTH INNOVATION THANK YOU TO OUR LEAD SPONSOR CANADA’S RESEARCH-BASED PHARMACEUTICAL COMPANIES

Add to Reading List

Source URL: www.csmb-scbm.ca

Language: English - Date: 2015-04-22 22:03:56
    2PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

    PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

    Add to Reading List

    Source URL: www.abbvie.ca

    Language: English - Date: 2018-07-18 19:08:19
      3Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada   We are seeking a highly motivated and experienced Postdoctoral Research Fellow to

      Postdoctoral Position in Computational Toxicology Co-hosted by CCAAM/CaCVAM, Health Canada, and Environment and Climate Change Canada   We are seeking a highly motivated and experienced Postdoctoral Research Fellow to

      Add to Reading List

      Source URL: stcweb.ca

      Language: English - Date: 2018-02-15 15:11:36
        4Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

        Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

        Add to Reading List

        Source URL: www.astrazeneca.ca

        Language: English - Date: 2017-11-11 05:51:44
          5PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

          PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

          Add to Reading List

          Source URL: www.abbvie.ca

          Language: English - Date: 2018-07-18 04:02:55
            6REQUEST FOR PROPOSALS Grand Challenges Canada at the McLaughlin-Rotman Centre for Global Health MaRS Centre, South Tower, 101 College Street, Suite 406, Toronto, Ontario, Canada M5G 1L7 TFE in

            REQUEST FOR PROPOSALS Grand Challenges Canada at the McLaughlin-Rotman Centre for Global Health MaRS Centre, South Tower, 101 College Street, Suite 406, Toronto, Ontario, Canada M5G 1L7 TFE in

            Add to Reading List

            Source URL: www.grandchallenges.ca

            Language: English - Date: 2016-10-04 13:30:51
              7Effects of Mental Disorders Stigma | Mental Health in Canada

              Effects of Mental Disorders Stigma | Mental Health in Canada

              Add to Reading List

              Source URL: www.schizophrenia.ca

              Language: English - Date: 2013-04-11 12:58:21
                8Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives

                Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives

                Add to Reading List

                Source URL: www.astrazeneca.ca

                Language: English - Date: 2017-11-16 21:16:49
                  9PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)  

                  PRESS RELEASE Health Canada Grants Priority Review to AbbVie’s Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)  

                  Add to Reading List

                  Source URL: www.abbvie.ca

                  Language: English - Date: 2018-07-18 07:06:17
                    10Canadian Health Coalition A New Health Accord and Beyond The last Health Accord expired in 2014, leaving Canada without stable funding for health care or a tool to enforce national standards of care

                    Canadian Health Coalition A New Health Accord and Beyond The last Health Accord expired in 2014, leaving Canada without stable funding for health care or a tool to enforce national standards of care

                    Add to Reading List

                    Source URL: www.healthcoalition.ca

                    Language: French - Date: 2016-09-16 16:01:01